Lingru Li

机构：Shandong University of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Chinese Preventive Medicine Association, Shandong First Medical University, University of Chinese Academy of Sciences · ORCID：0000-0003-3716-9304

发表论文 86 篇 · 总被引 1751 次 · h-index 24

代表论文

• A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders (2025 · Cell Discovery · 被引 112)
• Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products (2025 · Phytomedicine · 被引 55)
• Exploring the lipid-lowering effects of cinnamic acid and cinnamaldehyde from the perspective of the gut microbiota and metabolites (2025 · Food & Function · 被引 42)
• PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets (2024 · Journal of Advanced Research · 被引 34)
• Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota (2024 · Frontiers in Cellular and Infection Microbiology · 被引 30)
• AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease (2025 · Pharmacological Research · 被引 28)